This resolution establishes an advisory working group to study adding two women's portraits to the House Hall of Representatives. The group, composed of House officials, committee leaders, and bipartisan caucus co-chairs, will recommend specific women lawgivers, funding methods, installation plans, and a timeline to minimize disruption. The working group must submit its report within one year or by the end of the current Congress. This is a procedural step to review potential additions to existing relief portraits, not a funding or policy change.
This bill creates a federal program providing child care assistance to working families with children under age 6 through direct child care certificates that parents can use to pay for high-quality child care services. States must develop plans with payment rates covering provider costs and wages, sliding fee scales based on family income (with no copayment for families earning under 85% of state median income), and policies prioritizing vulnerable children including those with disabilities, experiencing homelessness, or from low-income families. The program requires providers to meet quality standards, prohibit suspensions/expulsions, and implement quality improvement activities while ensuring accessibility for underserved populations. It is funded through significant federal appropriations for fiscal years 2026-2031.
The Child Care for Working Families Act creates a federal program to provide affordable, high-quality child care for working families with children under age 6. It would provide direct child care assistance through certificates or grants to parents, with no copayment required for families at or below 85% of state median income. The program requires states to implement quality standards for child care providers, including a tiered quality system and minimum wage requirements for staff (at least a living wage equivalent to elementary educators). The bill appropriates $20 billion for the program over five years, with additional funding for quality improvement initiatives and universal preschool services.
HR 4396, the Uterine Cancer Study Act of 2025, mandates a study by the Department of Health and Human Services (HHS) into the potential link between chemical hair straighteners and uterine cancer, with a specific focus on higher incidence rates among women of color. The study will review existing research, examine impacts across all racial and ethnic groups, analyze different hair straightener types (including those with dyes or bleach), and assess whether the FDA should require additional safety testing for these products. HHS must submit its study methodology within 45 days of the bill's enactment, begin the study within 180 days, and deliver a final report to Congress within two years. This bill does not create new regulations but directs a specific research effort to gather evidence on a potential health concern. The study directly affects women, particularly women of color, who use hair straightening products and may face elevated uterine cancer risks.
This bill would allow states to create their own universal health care systems by applying for waivers that replace federal health programs with state-based coverage. States would need to demonstrate they can cover at least 95% of residents within 5 years, maintain comparable benefits and affordability, and provide comprehensive coverage including reproductive health services. The federal government would redirect funds that would have gone to federal programs like Medicaid and Medicare to the states, with states required to submit regular reports on coverage progress and costs. The bill includes specific protections for Indian health care providers and ensures coverage for vulnerable populations without imposing new costs on them. This framework would apply to states that choose to implement their own universal health care system rather than relying on existing federal programs.
HR 4388, the PREP Repeal Act, removes legal immunity for pharmaceutical companies that developed or distributed pandemic-related products (like vaccines or treatments) during public health emergencies. It repeals key sections of the PREP Act that previously shielded manufacturers from lawsuits over injuries or harm caused by these products. The bill ensures people can still pursue civil lawsuits under existing federal or state law for harm from drugs, devices, biological products, or pandemic countermeasures. This change applies only to cases pending or filed after the law's enactment, preserving current legal rights while ending the broad liability protection.
This bill changes the federal tax rate for hookah tobacco (also called waterpipe tobacco) from $2.83 per pound to $0.57 per pound, while keeping the higher tax rate for regular pipe tobacco. It directly affects manufacturers and importers of hookah tobacco products like shisha and maassel by lowering their tax burden. The bill also formally defines "waterpipe tobacco" to include common terms like hookah, shisha, and argileh, ensuring clear tax application. These changes apply to tobacco products manufactured or imported after the bill's enactment date.
This bill directs the Department of Health and Human Services to significantly increase federal research funding for uterine fibroids ($30 million annually from 2026-2030), expand coordination of NIH research, and establish a Medicaid data system to track treatment access and costs. It mandates public education on fibroid symptoms, prevalence (especially among Black women, who face higher risk and severity), and non-hysterectomy treatment options. The bill also requires disseminating evidence-based provider resources on managing fibroids while preserving fertility. These provisions directly affect the estimated 26 million U.S. women with fibroids - particularly women of color - and aim to address the current lack of research and treatment data.
This bill directs the Health and Human Services Secretary to fund research on early detection and intervention for uterine fibroids, aiming to develop evidence-based approaches for healthcare settings. It authorizes grants to states to support screening (including advanced imaging), patient navigation services, and public education campaigns focused on early detection, with priority given to areas with socially vulnerable populations at higher risk. The bill also funds research into disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. These provisions directly affect women with uterine fibroids, particularly in underserved communities, by expanding access to early detection services and targeted research.
This bill amends the Joint Chiefs Landscape Restoration Partnership program to expand its scope and improve coordination. It adds wildfire recovery and soil/water resource enhancement as eligible project purposes, requires the Natural Resources Conservation Service to coordinate with the Forest Service on science and management plans, and extends the program's authorization through 2031. The changes apply directly to federal agencies administering the program, including the Natural Resources Conservation Service and Forest Service, and affect projects managed under the partnership. Key provisions include updated wildfire risk assessments and alignment with state forest action plans. The bill makes concrete adjustments to existing program rules without creating new funding or altering core program eligibility.
This bill extends funding deadlines for sport fish restoration and recreational boating programs through 2031, updating prior expiration dates. It clarifies funding for interstate fisheries commissions and adds new definitions for alternative marine fuel infrastructure, including facilities dispensing fuels derived from recycled oils or plant materials. The bill also establishes a 3% tax rate (down from 10%) for portable, electronically-aerated bait containers sold by manufacturers. These changes primarily affect recreational boaters, sport fishing programs, and facilities seeking to install alternative fuel infrastructure.
HRES 579 is a non-binding resolution designating July as Uterine Fibroids Awareness Month. It supports raising public awareness about uterine fibroids - a condition affecting an estimated 80% of women by age 50 - particularly highlighting the disproportionate impact on Black and Hispanic women (3x and 2x higher rates than White women). The resolution recognizes the need for more research, treatment options, and education on fibroid prevention and symptoms. It urges the President to issue a proclamation encouraging nationwide awareness activities during July. This is a symbolic measure with no new funding or legal requirements.
